PDCD1 and glioma: Evidence suggests that in glioma LAG-3 expression is associated with CD3+, CD8+, CD20+ and PD-1+ tumor-infiltrating lymphocytes (TILs) and PD-L1+ tumor cells and hence were more frequently noted in samples with an active inflammatory microenvironment [42].